Stay updated on AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial

Sign up to get notified when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest has been deleted.
    Difference
    1%
    Check dated 2025-07-04T04:10:05.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.9%
    Check dated 2025-06-19T19:56:05.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:21:32.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T06:05:46.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T14:22:18.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page has undergone significant content removal regarding the details of the AFM24-102 study, including its phases, eligibility criteria, and specific cancer types being targeted. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    30%
    Check dated 2025-04-16T10:45:09.000Z thumbnail image

Stay in the know with updates to AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.